EORTC protocol 18841

Randomized phase II trial of two platinum derivatives : carboplatin (CBDCA) vs iproplatin (CHIP) in advanced malignant melanoma.
Trial StatusAll trial activities ended
DatesDate of activation: 15-Oct-84
Date Step1 close: 15-Mar-87
Date Step2 close: 01-Oct-88
Data management at EORTCFull
Phase2
Randomized trialYes
TypeAdvanced
Targeted Sample size38
Number of steps2
Drug
Study StaffUlrich Kleeberg (Study Coordinator) - H.O.P.A., Hamburg
Type of cancerMelanoma
Participating GroupsEORTC Melanoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section